| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas
Clin Mol Hepatol.2019;25(3):331-332.   Published online May 30, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0034
                              
Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
Rahul Kumar, John Chen Hsiang, Jessica Tan, Prem Harichander Thurairajah
Clin Mol Hepatol.2019;25(3):326-330.   Published online December 4, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0063
                              
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Mohamed Omar Abdel-Malek, Asmaa Omar Ahmed, Nourhan Mahmoud Abbas
Clin Mol Hepatol.2019;25(3):317-325.   Published online June 10, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0097
                              
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol.2019;25(3):305-316.   Published online April 19, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0004
                              
Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee
Clin Mol Hepatol.2019;25(3):294-304.   Published online May 30, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0086
                              
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol.2019;25(3):283-293.   Published online November 13, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0054
                              Supplementary         Cited By 1
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clin Mol Hepatol.2019;25(3):280-282.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0104
                              
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clin Mol Hepatol.2019;25(3):270-279.   Published online April 22, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0015
                                 Cited By 1
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol.2019;25(3):264-269.   Published online March 4, 2019     
DOI: https://doi.org/10.3350/cmh.2019.1001
                                 Cited By 2
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol.2019;25(3):245-263.   Published online February 14, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0090
                                 Cited By 2
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na, Byung-Cheol Song
Clin Mol Hepatol.2019;25(3):234-244.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0108
                                 Cited By 1
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol.2019;25(3):223-233.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0107
                                 Cited By 1
VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature
Yu Jun Wong, Si Yuan Chew, John Chen Hsiang, Prem Harichander Thurairajah, Rahul Kumar, Eng Kiong Teo, Roshni Sadashiv Gokhale, Imran Bin Mohamed Noor, Jessica Tan
Clin Mol Hepatol.2019;25(2):218-222.   Published online September 6, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0017
                                 Cited By 2
Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt
Dongmei Zhao, Guobing Zhang, Mingquan Wang, Chaoxue Zhang, Jiabin Li
Clin Mol Hepatol.2019;25(2):210-217.   Published online March 22, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0083
                              
Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
Manoj Kumar Sharma, Sumeet Kainth, Sachin Kumar, Ankit Bhardwaj, Hemant Kumar Agarwal, Rakhi Maiwall, Kapil Dev Jamwal, Saggere Muralikrishna Shasthry, Ankur Jindal, Ashok Choudhary, Lovkesh Anand, Rajender Mal Dhamija, Guresh Kumar, Barjesh Chander Sharma, Shiv Kumar Sarin
Clin Mol Hepatol.2019;25(2):199-209.   Published online March 11, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0084
                              
Evaluation of bioenergetic and mitochondrial function in liver transplantation
Rui Miguel Martins, João Soeiro Teodoro, Emanuel Furtado, Anabela Pinto Rolo, Carlos Marques Palmeira, José Guilherme Tralhão
Clin Mol Hepatol.2019;25(2):190-198.   Published online March 22, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0087
                              
Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis
Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka
Clin Mol Hepatol.2019;25(2):183-189.   Published online November 9, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0039
                                 Cited By 1
Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices
Jin Wook Chung
Clin Mol Hepatol.2019;25(2):181-182.   Published online December 21, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1010
                              
Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol.2019;25(2):172-180.   Published online February 12, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0106
                                 Cited By 3
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol.2019;25(2):168-171.   Published online February 11, 2019     
DOI: https://doi.org/10.3350/cmh.2018.1014
                              
Advances in ultrasound diagnosis in chronic liver diseases
Hitoshi Maruyama, Naoya Kato
Clin Mol Hepatol.2019;25(2):160-167.   Published online February 18, 2019     
DOI: https://doi.org/10.3350/cmh.2018.1013
                              
KASL clinical practice guidelines for management of chronic hepatitis B
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2019;25(2):93-159.   Published online June 12, 2019     
DOI: https://doi.org/10.3350/cmh.2019.1002
                              Supplementary         Cited By 7
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim
Clin Mol Hepatol.2019;25(1):86-91.   Published online August 28, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0005
                              Supplementary         Cited By 1
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol.2019;25(1):74-85.   Published online February 28, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0072
                              
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol.2019;25(1):65-73.   Published online February 25, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0070
                              
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol.2019;25(1):52-64.   Published online October 23, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0040
                                 Cited By 3
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol.2019;25(1):42-51.   Published online November 19, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0029
                              Supplementary         Cited By 1
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
Won Kim
Clin Mol Hepatol.2019;25(1):40-41.   Published online December 28, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0101
                                 Cited By 1
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Young Woo Eom, Soon Koo Baik
Clin Mol Hepatol.2019;25(1):37-39.   Published online December 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1011
                                 Cited By 1
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol.2019;25(1):30-36.   Published online January 23, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0061
                                 Cited By 1
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 466
TOTAL : 268930